echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > New research suggests that people infected with the new coronavirus have a smaller risk of re-infection but still need protection

    New research suggests that people infected with the new coronavirus have a smaller risk of re-infection but still need protection

    • Last Update: 2020-12-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The occurrence of SARS-CoV-2 PCR-positive results was observed based on the baseline state of the anti-SRAS-CoV-2 hedgehog protein IgG antibody.
    from NEJM, 2020, doi:10.1056/NEJMoa2034545.
    these results bode well for the vaccine, which stimulates the immune system to produce antibodies attached to SARS-CoV-2, helping to eliminate the virus.
    the first study, Dr. Ned Sharpless, director of the National Cancer Institute, said the researchers found that people who received antibodies from natural infections were "much less at risk . . . The same protection you get from an effective vaccine "prevents re-infection with the virus."
    he said re-infection was "very, very rare."
    first study was not related to --- many U.S. federal researchers turned to coronavirus research because of the COVID-19 pandemic.
    two types of tests were used in both studies.
    is an antibody that can stay in the blood for several months after infection.
    another type of test that uses the nasal cavity or other samples to detect the SARS-CoV-2 virus itself or its fragments, indicating current or recent infections.
    study involved more than 12,500 health workers at Oxford University Hospital in the UK.
    of the 1,265 people who initially had SARS-CoV-2 antibodies tested positive for active infection over the next six months, and neither showed symptoms.
    contrasts with 11,364 workers who initially did not have SARS-CoV-2 antibodies, 223 of whom tested positive for infection within about six months.
    study involved more than 3 million people who tested for SARS-CoV-2 antibodies from two private laboratories in the United States.
    only 0.3% of those who initially had antibodies tested positive for SARS-CoV-2 coronavirus, compared with 3% of those without antibodies.
    "it's very gratifying," said Sharpless, a researcher in the second study, who observed a 10-fold reduction in the risk of re-infection if antibodies were present.
    Joshua Wolf, an infectious disease specialist at St. Jude Children's Research Hospital in the United States who was not involved in both studies, said the findings were "not surprising . . . but they are reassuring because they tell people that immunity to the virus is very common."
    " he said, antibodies themselves may not provide protection, they may only be other parts of the immune system (such as T-cells) can resist any new virus exposure signals.
    we don't know how long this immunity will last," Wolf added.
    "more than one case of SARS-CoV-2 infection has been confirmed, so "people still need to protect themselves and others by preventing re-infection."
    (Bio Valley Bioon.com) Reference: 1. Raymond A. Harvey et al. Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection. medRxiv, 2020, doi:10.1101/2020.12.18.20248336. 2.Sheila F. Lumley et al. Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers. NEJM, 2020, doi:10.1056/NEJMoa2034545. 3.Studies find having COVID-19 may protect against reinfection。
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.